125 related articles for article (PubMed ID: 30003677)
1. Bilateral uveal melanoma: hunting for the source.
Shields CL; Masoomian B; Shields JA
Clin Exp Ophthalmol; 2018 Jul; 46(5):459-461. PubMed ID: 30003677
[No Abstract] [Full Text] [Related]
2. Correlation of Immunocytochemistry of BRCA1-associated Protein-1 (BAP1) With Other Prognostic Markers in Uveal Melanoma.
Glasgow BJ; McCannel TA
Am J Ophthalmol; 2018 May; 189():122-126. PubMed ID: 29530782
[TBL] [Abstract][Full Text] [Related]
3. Molecular alternations in uveal melanoma.
Materin MA; Faries M; Kluger HM
Curr Probl Cancer; 2011; 35(4):211-24. PubMed ID: 21911184
[No Abstract] [Full Text] [Related]
4. Role of somatic mutations and chromosomal aberrations in the prognosis of uveal melanoma in a Spanish patient cohort.
Silva-Rodríguez P; Bande M; Fernández-Díaz D; Lago-Baameiro N; Pardo M; José Blanco-Teijeiro M; Domínguez F; Loidi L; Piñeiro A
Acta Ophthalmol; 2021 Nov; 99(7):e1077-e1089. PubMed ID: 33421325
[TBL] [Abstract][Full Text] [Related]
5. A review of advanced genetic testing for clinical prognostication in uveal melanoma.
Werdich XQ; Jakobiec FA; Singh AD; Kim IK
Semin Ophthalmol; 2013; 28(5-6):361-71. PubMed ID: 24010756
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.
Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J
Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874
[TBL] [Abstract][Full Text] [Related]
7. Uveal Melanoma Nuclear BRCA1-Associated Protein-1 Immunoreactivity Is an Indicator of Metastasis.
Szalai E; Wells JR; Ward L; Grossniklaus HE
Ophthalmology; 2018 Feb; 125(2):203-209. PubMed ID: 28823399
[TBL] [Abstract][Full Text] [Related]
8. Uveal Melanoma in BAP1 Tumor Predisposition Syndrome: Estimation of Risk.
Singh N; Singh R; Bowen RC; Abdel-Rahman MH; Singh AD
Am J Ophthalmol; 2021 Apr; 224():172-177. PubMed ID: 33316260
[TBL] [Abstract][Full Text] [Related]
9. Clinical Characteristics of Uveal Melanoma in Patients With Germline BAP1 Mutations.
Gupta MP; Lane AM; DeAngelis MM; Mayne K; Crabtree M; Gragoudas ES; Kim IK
JAMA Ophthalmol; 2015 Aug; 133(8):881-7. PubMed ID: 25974357
[TBL] [Abstract][Full Text] [Related]
10. Tumours associated with BAP1 mutations.
Murali R; Wiesner T; Scolyer RA
Pathology; 2013 Feb; 45(2):116-26. PubMed ID: 23277170
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of germline BAP1 mutation in a population-based sample of uveal melanoma cases.
Aoude LG; Vajdic CM; Kricker A; Armstrong B; Hayward NK
Pigment Cell Melanoma Res; 2013 Mar; 26(2):278-9. PubMed ID: 23171164
[No Abstract] [Full Text] [Related]
12. Estimating Cured Fractions of Uveal Melanoma.
Singh AD; Zabor EC; Radivoyevitch T
JAMA Ophthalmol; 2021 Feb; 139(2):174-181. PubMed ID: 33355644
[TBL] [Abstract][Full Text] [Related]
13. Histomorphologic spectrum of BAP1 negative melanocytic neoplasms in a family with BAP1-associated cancer susceptibility syndrome.
Marušić Z; Buljan M; Busam KJ
J Cutan Pathol; 2015 Jun; 42(6):406-12. PubMed ID: 25902915
[TBL] [Abstract][Full Text] [Related]
14. Improving risk estimates of metastasis from uveal melanoma through mutation profiling.
Kivelä T; Jager MJ
Invest Ophthalmol Vis Sci; 2014 Aug; 55(8):5168. PubMed ID: 25143043
[No Abstract] [Full Text] [Related]
15. Germline BAP1 alterations in familial uveal melanoma.
Rai K; Pilarski R; Boru G; Rehman M; Saqr AH; Massengill JB; Singh A; Marino MJ; Davidorf FH; Cebulla CM; H Abdel-Rahman M
Genes Chromosomes Cancer; 2017 Feb; 56(2):168-174. PubMed ID: 27718540
[TBL] [Abstract][Full Text] [Related]
16. BAP1 expression is prognostic in breast and uveal melanoma but not colon cancer and is highly positively correlated with RBM15B and USP19.
Shahriyari L; Abdel-Rahman M; Cebulla C
PLoS One; 2019; 14(2):e0211507. PubMed ID: 30716094
[TBL] [Abstract][Full Text] [Related]
17. DNA damage response proteins and its role in tumor progression of uveal melanoma with patient outcome.
Kashyap S; Jha J; Singh MK; Singh L; Sen S; Kaur J; Bajaj MS; Pushker N
Clin Transl Oncol; 2020 Sep; 22(9):1472-1480. PubMed ID: 32124242
[TBL] [Abstract][Full Text] [Related]
18. Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development.
Figueiredo CR; Kalirai H; Sacco JJ; Azevedo RA; Duckworth A; Slupsky JR; Coulson JM; Coupland SE
J Pathol; 2020 Apr; 250(4):420-439. PubMed ID: 31960425
[TBL] [Abstract][Full Text] [Related]
19. Germline BAP1 mutations also predispose to cutaneous squamous cell carcinoma.
Rawson RV; Watson GF; Maher AM; McCarthy SW; Thompson JF; Scolyer RA
Pathology; 2017 Aug; 49(5):539-542. PubMed ID: 28693747
[No Abstract] [Full Text] [Related]
20. BAP1 Germline Mutations in Finnish Patients with Uveal Melanoma.
Turunen JA; Markkinen S; Wilska R; Saarinen S; Raivio V; Täll M; Lehesjoki AE; Kivelä TT
Ophthalmology; 2016 May; 123(5):1112-7. PubMed ID: 26876698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]